Metraipolis › archive › dc_2a0af010cd9b

Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies — Europe PMC PMID:42367781

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42367781
DOI
10.3389/fimmu.2026.1861111
License (as archived)
solo-consultazione
Archived
2026-10-31T13:47:01.186Z
SHA-256 of the archived text
5f424302fc72f53ef98adcd530307758062df8f56cceb1c41f63eb9aa2f0213d
Stable URL of this page
https://metraipolis.com/documento/dc_2a0af010cd9b

How to cite

Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies — Europe PMC PMID:42367781 — Europe PMC (en), https://europepmc.org/article/MED/42367781 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a0af010cd9b (Metraipolis archive dc_2a0af010cd9b, sha256 5f424302fc72f53ef98adcd530307758062df8f56cceb1c41f63eb9aa2f0213d)
BibTeX
@misc{dc2a0af010cd9b,
  title = {Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies — Europe PMC PMID:42367781},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42367781},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a0af010cd9b; sha256 5f424302fc72f53ef98adcd530307758062df8f56cceb1c41f63eb9aa2f0213d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42367781. Agents can read the archived copy with the MCP tool read_document.